No credit card. No commitment.
5000+ G2 reviews
NodThera
Research
Founded in 2016
Boston, MassachusettsNodThera
ResearchFounded in 2016Boston, Massachusetts
EmployeesNodThera's financial review
NodThera's Revenue (Yearly)
24.5M
Employees
26
Total Funding
95M
Last Funding Round
55M
NodThera information
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We're building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.
NodThera industries
Research
Biotechnology research
NodThera's financial review
NodThera's Revenue (Yearly)
24.5M
Employees
26
Total Funding
95M
Last Funding Round
55M
Employee Metrics
Technologies
Other
Load Balancers
Tag Management
Financial Software
Other
Notable Alumni
Employees
Associate Director Clinical Operations
Vice President of Business Development & Strategy
Senior Director of Translational Science
VP, Medicinal Chemistry
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
